Research on pain-relieving drugs. Covers new pain-management startups, omega-3 approaches, drug safety, and AI-driven drug discovery.
A study of high school seniors found that most who took opioid medications without a prescription did so for reasons other than pain relief, including relaxation and getting high. Students who used the drugs only for pain relief were less likely to engage in heavy drinking or other substance use.
A new treatment method, Vesselplasty, has been shown to reduce pain and improve mobility in patients with vertebral compression fractures. The study, which included 29 patients, found significant improvements in pain scores and mobility, with no clinical complications reported.
Scientists have developed a more efficient method to produce a novel form of acetaminophen with reduced liver toxicity risk, offering a potential solution to the growing concern over the drug's effects.
The review examines the prevalence of prescription opioid addiction among patients and healthcare providers, citing risks and consequences. New approaches to minimize abuse and promote recovery are discussed, emphasizing the importance of awareness and treatment.
A phase III randomised controlled trial found that famotidine reduces the development of stomach ulcers by 90% and upper-intestinal ulcers by 95% compared to placebo. The study also showed fewer adverse events in the famotidine group.
A randomized trial of 200 patients found that midline and transverse incisions had the same healing process and post-surgical pain perception. However, wound infections were more frequent for transverse incisions, possibly due to circulatory problems.
Cancer patients often suffer from severe pain due to tumors releasing signal substances that make nerve cells sensitive; a new approach involves injecting proteins that block these effects. This discovery opens up new prospects in the fight against cancer pain and potentially reduces side effects for patients.
A study of 133 women with rheumatoid arthritis found that symptoms such as pain and depression significantly impacted sleep quality. Treating depression may also improve pain and medication adherence, according to researchers.
Aspirin use in primary prevention reduces non-fatal heart attacks by around 12%, mainly due to reduced risk of non-fatal heart attack. However, it also increases the risk of internal bleeding by around a third in healthy individuals.
According to a University of Pittsburgh study, African-American seniors are two times more likely than whites to prefer life-prolonging treatments when faced with a terminal illness. The majority of Medicare beneficiaries surveyed preferred not to die in a hospital or receive life-sustaining measures at the end of life.
Researchers developed a strategy to improve both depression and pain management by closely monitoring antidepressant therapy and providing pain self-management training. The study found that this approach led to substantial improvements in both conditions, with benefits lasting six months after treatment was completed.
A combined pharmacological and behavioral intervention improved depression and pain in patients with musculoskeletal pain and co-existing depression. The intervention significantly reduced symptoms of both conditions at 12 months.
Scientists at Yale School of Medicine and Hydra Biosciences have discovered that a protein called TRPA1 may be a trigger of allergy-induced asthma in mice. Inhibiting this protein with a drug known for reducing pain could also reduce asthma symptoms, providing new hope for treatment.
A study published in PNAS identified TRPA1 as playing a key role in allergic asthma and demonstrated that HC-030031 effectively treated the condition in mice. This breakthrough research could represent a new avenue of treatment for asthma.
A new study by the University of Pennsylvania School of Medicine found that women with chest pain are less likely to receive recommended treatments, such as aspirin and nitroglycerin, from paramedics. This disparity in care may be due to differences in symptom interpretation or patient communication, emphasizing the importance of direc...
A new study comparing three different types of aspirin has found that chewable aspirin consistently shows greater and more rapid absorption, potentially leading to improvements in heart attack care. Researchers measured blood levels of aspirin after administering regular and chewed aspirin to volunteers.
A meta-analysis of studies on aspirin therapy found a 12% reduced risk of nonfatal stroke in patients with peripheral artery disease, although this finding was not statistically significant. Aspirin monotherapy was also associated with a lower risk of nonfatal stroke, but no significant reductions were seen in other cardiovascular events.
A study has found a genetic marker linked to the risk of acetaminophen-induced liver injury in humans. The researchers used a genetically diverse population of mice to identify a gene called CD44, which is significantly associated with elevated serum ALT levels.
A University of Rochester Medical Center survey found teens lack knowledge about over-the-counter pain medications, with only 35% correctly identifying acetaminophen and Tylenol. Chronic misuse can lead to liver damage and accidental overdose
A recent report by the Royal College of Physicians found that up to a quarter of stroke patients do not receive optimal treatment in specialist units. The editorial advocates for increased public awareness and priority for stroke care, citing the importance of rapid recognition and admission to acute units.
The HJF has released the Military Advanced Regional Anesthesia and Analgesia Handbook, providing education on advanced battlefield regional anesthesia techniques and acute pain medicine. The handbook aims to manage the pain of combat trauma and is intended for use by deployed medical forces.
Researchers at Hebrew University found that administering morphine with a drug blocking interleukin-1 provides effective long-term pain relief without increasing dosages. This breakthrough could lead to better pain management with lower side effects.
Researchers studied 2,736 participants over 12 years and found a 66% higher risk of dementia among heavy NSAID users. The study suggests that earlier findings suggesting NSAIDs prevent or delay Alzheimer's disease may have been due to younger age groups.
Researchers found that heavy NSAID use increased the risk of dementia by 66% among study participants. Despite initial findings suggesting a potential preventive effect, this new study indicates that NSAIDs only delay the onset of Alzheimer's disease. The study analyzed data from over 2,700 individuals and followed them for 12 years.
Researchers have discovered that proton pump inhibitors, commonly used to treat ulcers, have significant neuroprotective properties and can enhance the effects of ibuprofen when used together. This finding suggests a new treatment potential for Alzheimer's disease.
A low-dose of naltrexone reduced symptoms of pain and fatigue by an average of 30% in women with fibromyalgia, according to a Stanford pilot study. The drug's use was found to be particularly promising due to its low cost and limited side effects.
Cerebral microbleeds, small deposits of hemosiderin in the brain, are more common among older adults taking anti-clotting medications like aspirin. The study found an association between these medications and brain microbleeds, particularly among those taking higher doses.
Researchers found that acupressure wristbands reduced nausea by 23.8% in cancer patients undergoing radiation treatment, with no difference between the two wristband groups.
Researchers found that repeated exposure to similar temptations can enhance self-control, while a single tempting experience can wear down resistance. The studies showed that participants who had previously faced similar options performed better in subsequent decisions.
A polypill containing a statin, aspirin, and three blood pressure-lowering drugs significantly reduced systolic and diastolic blood pressure in healthy individuals. The formulation also lowered LDL cholesterol, heart rate, and urinary 11-dehydrothromboxane B2, but to a lesser extent than with individual components alone.
A study published in the journal Pain found oxycodone to be an effective treatment for acute shingles pain, with patients experiencing a significant reduction in pain levels. The medication was more than twice as effective as a placebo in reducing pain, making it a promising option for treating this debilitating condition.
Research suggests that aspirin can reduce the risk of polyps forming in the colon or rectum, a precursor to colorectal cancer. Studies have shown mixed results regarding the optimal dose and duration of use, but experts call for more evidence on the effects of aspirin on cancer.
A Mayo Clinic study found a correlation between inadequate vitamin D levels and the amount of narcotic medication taken by patients with chronic pain. Patients with low vitamin D levels were taking nearly twice as much pain medication, experiencing worse physical functioning and overall health perception.
The USPSTF updated its guidelines to recommend aspirin use for primary prevention of heart attack and stroke in specific age and gender groups. The task force emphasizes the importance of discussing the benefits and risks of daily aspirin use with patients, particularly those between 45-79 years old.
The US Preventive Services Task Force (USPSTF) recommends taking aspirin in at-risk patients to prevent heart attacks and strokes. However, the quality of care in nursing homes remains suboptimal, and creating a specialized physician training program may help address this issue.
A new study by the Women's Health Initiative (WHI) found that regular aspirin use reduced the risk of death from cardiovascular disease by 25% in postmenopausal women. The study also suggested a lower dose of aspirin (81mg) is as effective as a higher dose (325mg) in reducing mortality rates.
Aspirin inhibits H. pylori growth and enhances susceptibility to metronidazole, clarithromycin and amoxicillin by affecting outer membrane protein expression and increasing endocellular antimicrobial concentrations.
Researchers at University at Buffalo link capsaicin's analgesic effects to PIP2 lipid in cell membranes. The receptor's adaptation property allows it to continuously respond to varying stimuli, providing a novel strategy for developing safe pain-relieving medications.
Researchers found that H2RA therapy was effective in preventing and treating low-dose aspirin-induced peptic ulcers, while PPIs showed similar results. Cytoprotective anti-ulcer drugs were ineffective in preventing peptic ulcers. The study suggests a therapeutic strategy for managing this condition.
Researchers measure discomfort in cattle undergoing procedures like castration and dehorning using equipment similar to a jogger's heart rate monitor. The study aims to improve pain management in livestock by assessing the effectiveness of pharmaceuticals and recommending proper dosing. By analyzing various measurements, including skin...
Researchers at the University of Liverpool found that 15% of hospital patients experience adverse drug reactions, increasing hospital stay length. The study suggests that elderly patients on multiple medications are most susceptible to ADRs.
A study found that lack of general treatment failure and distant metastases 3 years after treatment initiation may be surrogate endpoints for long-term survival in early prostate cancer patients. Another study identified netrin-1 as a potential therapeutic target for non-small cell lung cancer.
The American Pain Society and American Academy of Pain Medicine have published comprehensive clinical practice guidelines to assist clinicians in prescribing potent opioid pain medications for patients with chronic non-cancer pain. The guidelines emphasize the importance of monitoring patients on chronic opioid therapy to weigh benefit...
The new guideline provides recommendations for clinicians on how to safely prescribe potent opioid pain medications for patients with chronic non-cancer pain. Key findings include the importance of careful patient selection, monitoring, and ongoing assessment to minimize risks of abuse and addiction.
Overdoses of acetaminophen lead to two waves of liver cell destruction and immune system activation. Aspirin is found to downregulate pro-inflammatory cytokine production, providing substantial protection from acetaminophen-induced liver damage.
A Yale study suggests simple aspirin can prevent liver damage from common drug side effects, alcohol abuse, and obesity-related diseases. The study found that aspirin reduced mortality caused by an overdose of acetaminophen and blocked inflammation pathways.
Fibromyalgia patients experience disability and reduced quality of life due to chronic pain and fatigue. Antidepressant medications have been found to improve symptoms by reducing pain, improving sleep, and boosting mood.
COX2 in brain and spinal cord nerve cells plays a crucial role in pain caused by inflammation, particularly mechanical inflammatory pain. Mice lacking COX2 in nerve cells have impaired hypersensitivity to pain caused by physical insult, suggesting COX2 is central to this type of pain.
A study by Seong-Hyun Park and Richard H. Mattson found that hospital patients with plants in their rooms had fewer intakes of pain medication and more positive physiological responses. Patients interacted with the plants, such as watering and pruning, indicating a therapeutic benefit.
A recent study published in the World Journal of Gastroenterology investigated the gastrointestinal side effects of high-dose acetaminophen and NSAIDs. The research found that gastric lesions were similar between groups, indicating that acetaminophen is not entirely free of gastrointestinal side effects at high doses.
Researchers have discovered that people naturally produce salicylic acid (SA) in their bodies, which is also found in fruits and vegetables. This finding suggests SA may play a role as an animal bioregulator in fighting inflammation and disease.
A commonly-prescribed drug for men suffering from pelvic pain failed to significantly reduce symptoms in a 12-week international study. Researchers can now focus on more promising therapies.
A proteomics study found that numbing drugs can have profound effects on the developing nervous system, even after minimal exposure. The study highlights the need for caution when administering sedatives or anesthetics to pregnant women or infants.
A new study reveals a sharp decline in NIH pain research funding, now accounting for only 0.6% of all grants awarded, despite the high prevalence of chronic pain in the US population. The American Pain Society calls for increased funding to address this pressing public health issue.
Researchers developed a new class of anti-inflammatory drugs with fewer side effects than aspirin, targeting the later stage of arachidonic acid biosynthesis. These dual mPGES-1/5-LO-Inhibitors effectively target both prostaglandins and leukotrienes, promising more effective results for inflammatory reactions.
A study found that most unintentional overdose deaths in West Virginia were associated with the nonmedical use and diversion of pharmaceuticals, primarily pain relievers. The majority of decedents had a history of substance abuse and used multiple contributory substances.
Two pivotal Phase 3 trials evaluating HZT 501 met primary endpoints, showing a statistically significant reduction in gastrointestinal ulcers compared to ibuprofen alone. The treatment also demonstrated good tolerability and was well-received by patients.
Scientists have determined that pain and itch are regulated by different molecular mechanisms. Researchers at WashU Medicine separated itch and pain sensations in mice, a finding that could have important implications for treating both pain and chronic itching. GRPR gene plays key role in transmitting itching sensations.
Researchers found that men taking aspirin had significantly lower PSA levels, especially among those with prostate cancer. However, this may affect the ability to detect early-stage prostate cancer through PSA screening.
A new study published in JAMA found that low-dose aspirin did not significantly reduce the risk of atherosclerotic events, including coronary and cerebrovascular events, in patients with type 2 diabetes. However, aspirin was effective in reducing fatal coronary and fatal cerebrovascular events.